Adverse Childhood Environment Tied to Later Health Problems
Increased risk for all-cause mortality remained significant in fully adjusted model
Certain Tumor Markers Also Tied to Heart Failure Outcomes
Tumor biomarkers may be indicators of heart failure severity, progression, mortality
COVID-19 Mortality Higher for Those Not Taking Meds for Their HTN
Mortality similar with renin-angiotensin-aldosterone system inhibitor, non-RAAS inhibitor for HTN
COVID-19 Drug Studies Questioned
Journals issue 'expressions of concern' over two recent studies of medications and their effect on COVID-19 patients
Women’s Acute Coronary Symptoms No Longer ‘Atypical’
Chest pain remains the most common presentation by both men and women
Reducing Number of BP Meds May Be Safe in Some Older Adults
No significant change in systolic BP control seen at 12 weeks versus pretrial medication
Weight, Blood Pressure Higher in Younger Patients With T2DM
Differentials for weight, BP for those with, without T2DM greater for younger versus older patients
Doxycycline Does Not Cut Growth of Abdominal Aortic Aneurysms
Compared with placebo, no difference seen in growth of small abdominal aortic aneurysms at two years
ACE Inhibitors, ARBs Not Linked to In-Hospital COVID-19 Death
Risk for in-hospital death increased with age >65, underlying cardiovascular disease, COPD, smoking
Hydroxychloroquine Plus Macrolides No Benefit in COVID-19
Hydroxychloroquine, chloroquine with or without macrolides linked to in-hospital mortality, arrhythmia
